difference between gip and glp 1 Two incretin hormones GLP-1 GIP: Comparison of their actions in insulin secretion and β cell preservation Medical Weight Loss GLP-1/GIP |

Preclinical studies have shown KPV significantly reduces the severity of intestinal inflammation, decreases pro-inflammatory cytokine activity, and supports intestinal barrier repair

It helps improve stamina, supports healthy nerve function and enhances red blood cell production which is vital for oxygen transport and overall vitality

MC4 receptor engagement leads to appetite suppression and occasional weight loss

A head-to-head comparison revealed that both semaglutide and tirzepatide reduced the composite risk of hospitalization for HF or all-cause mortality by over 40% relative to placebo, with no significant advantage of tirzepatide over semaglutide

By Region : North America Europe APAC Latin America MEA Asia Pacific held a sizable revenue share in the global GLP-1 receptor agonist market and is set to witness substantial development by 2032, attributed to the rising prevalence of diabetes driven by factors, such as changing lifestyles, unhealthy diets, and sedentary habits, which is contributing to the increasing demand for effective diabetes management drugs